Board of Directors

Board of Directors

Mats Forsman
Chairman of the Board
Born 1947, Board member since 2018

Mats Forsman has more than 30 years’ experience in senior production and marketing roles at AstraZeneca. Mats also has extensive experience from the innovation system in Umeå through various roles within Innovationsbron Umeå AB and Umeå Universitet Holding AB, as well as through own enterprises.

Other ongoing assignments: Chairman of the Board at Inficure Bio AB and Airframe AB, deputy board member at Forsman i Kråken AB 

Bengt Furberg
Director of the Board
M.D., Ph.D. Born 1941, 
Board member since 2014

Bengt Furberg has extensive experience in life science industries, including 10 years as Medical Director for Glaxo Wellcome’s Swedish operations. Bengt has also held the role of Medical Director of several companies in the medical device industry. Mr Furberg’s extensive medical experience has resulted in the publication of more than 40 scientific articles, covering fields that include sports medicine and clinical trials.

Other ongoing assignments: Board member of Redwood Pharma AB (publ), Hamlet Pharma AB (publ), BrainCool AB (publ), Solutio AB and Selectimmune Pharma AB.

Anders Hansson
Director of the Board
Born 1953,  Board member since 2018

Anders Hansson has served as administrative and financial Director in listed companies as well as private entities, and has been responsible for sales of companies as well as initial public offerings. Anders Hansson was a board member of CTT systems 1997-2001 and was in charge the CTT’s initial public offering in 1997.

Iman Ziai
Director of the Board
Born 1983, Board member since 2018

Iman Ziai holds a master’s degree in Business Administration and has 12 years of experience from international project management and process optimization, as well as financial and accounting services through his own companies.

Other ongoing assignments:
Director of the Board LTZ Capital AB.